| Mepha Pharma AG - Ambrisentan-Mepha 5 mg, Lactab | | 67294 | | 01 | | Ambrisentan-Mepha 5 mg | | Lactab | | C02KX02 | | Ambrisentan | | 27.10.2020 | | |
| | Composition | | ambrisentanum 5 mg, lactosum monohydricum 75 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.11 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Lactose Monohydrate | 75 mg | | | Lecithinum ex Soja | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 990.57 | 1093.70 | B | SL | Yes |
|
|
